Company
Headquarters: Yicheng, China
Employees: 439
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Hubei Goto Biopharm Co.,Ltd. engages in the production and sale of steroid hormone API's and intermediates in China. It offers starting materials, such as 9a-hydroxy-4-androstenedione(9a-OHAD), bisnoralcohol(BA), sitolactone, 1.4-androstadienedione(ADD), and 4-androstenedione(4-AD); intermediates, including estrogens, progesterone, nonsteroids, other hormones, and corticosteroids; and other pharmaceutical raw materials. The company was founded in 2006 and is based in Yicheng, China.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Hubei Goto Biopharm Co.,Ltd. has the following listings and related stock indices.
Stock: SZSE: 300966 wb_incandescent